Delano Ladd

EVP Delano Ladd sells 7,500 HQY shares at $90.00 under 10b5-1 plan; stock down -22.3% from 52-week high

Delano Ladd, EVP and General Counsel, sold 7,500 shares at $90.00 for a total value of $675,000.00, reducing his holdings from 98,641 to 91,141 shares. This sale is part of a pre-arranged 10b5-1 trading plan adopted on 2025-06-12 and is therefore scheduled rather than discretionary. The stock is currently trading 22.3% below its 52-week high of $116.65, though it has gained 10.0% over the past 30 days and 12.7% over the past 90 days. His prior trades at HQY over three distinct sales showed mixed results, with 30-day returns ranging from -2.6% to -4.4% and 90-day returns from -0.2% to +1.7%.

EVP/General Counsel Delano sells 6,000 shares at blended $94.11 for $564.6K, reducing stake to 79.5K shares.

Ladd Delano, as EVP and General Counsel of HealthEquity, executed three separate sales totaling 6,000 shares for $564,647.35 on 2025-09-19. The blended average price of $94.11 sits below the current price of $95.97 and well within the 52-week range of $76.77–$114.51. With annual revenue growth of 20.0% and net income of $59.9M on $325.8M in quarterly revenue, HealthEquity shows solid operational growth, though the P/E of 56.79 reflects a premium valuation. Post-transaction, Delano retains 79.5K shares, representing a 7.0% reduction from his prior 85.5K shares. The sale occurred on a day when the stock was up 6.8% over 30 days but down 7.9% over 90 days, placing it 16.2% below its 52-week high.